Suggests measuring a nadir GH level after an oral glucose load in patients with a postoperative random GH greater than 1 µg/L. Use to further evaluate GH suppression when baseline GH is elevated postoperatively.
Scanned 9/9/2026
Install to Claude Code
npx -y skills add dromlakhani/MD2SKILL --skill endo-postop-nadir-gh-ogtt-if-ghgt1 --agent claude-codeInstalls into .claude/skills of the current project.
Are you the author of Endo Postop Nadir Gh Ogtt If Ghgt1?
Add the live security badge to your README — it updates automatically with every re-scan.
[](https://www.skillsdirectory.com/skills/dromlakhani-endo-postop-nadir-gh-ogtt-if-ghgt1)More formats (shields.io, HTML) on the badges page.
---
name: endo-postop-nadir-gh-ogtt-if-ghgt1
description: Suggests measuring a nadir GH level after an oral glucose load in patients with a postoperative random GH greater than 1 µg/L. Use to further evaluate GH suppression when baseline GH is elevated postoperatively.
---
# Measure nadir GH after glucose load if postoperative GH >1 µg/L
## STEP 1 — Gather Information
Confirm postoperative timing ≥12 weeks after transsphenoidal surgery; obtain serum IGF-1 and random GH levels.
## STEP 2 — Rule In / Rule Out
Is random GH >1 µg/L? If NO, consider biochemical remission (especially if IGF-1 normal) and routine follow‑up. If YES, proceed to oral glucose tolerance test (OGTT) for nadir GH measurement.
## STEP 3 — Classify or Stratify
Perform OGTT (75 g glucose) and measure nadir GH at 0, 30, 60, 90, 120 min; classify as suppressed if nadir GH <1 µg/L, not suppressed if nadir GH ≥1 µg/L.
## STEP 4 — Decide
If nadir GH suppressed (<1 µg/L), continue routine surveillance with IGF-1 and random GH every 6‑12 months. If nadir GH not suppressed (≥1 µg/L), consider persistent disease and discuss repeat surgery, medical therapy, or radiotherapy with multidisciplinary team.
## Clinical Guardrails / Mimics / Pitfalls
Do not measure GH <12 weeks post‑op due to surgical stress‑induced elevations; ensure fasting state and verify hyperglycemia during OGTT to avoid false‑negative suppression; use assay with adequate sensitivity at low GH levels; do not rely solely on random GH without IGF-1 context; avoid interpreting a single nadir GH without confirming glucose load adequacy.
## Concrete Clinical Example
A patient 4 months postoperatively has random GH 1.8 µg/L and IGF-1 above age‑adjusted norm. OGTT yields nadir GH 0.9 µg/L (<1 µg/L), indicating adequate suppression; patient continues routine monitoring. Another patient with random GH 2.2 µg/L has nadir GH 1.6 µg/L (≥1 µg/L), prompting discussion of repeat surgery or initiation of somatostatin receptor ligand therapy.
**Source:** Acromegaly: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2014, DOI:10.1210/jc.2014-2700
> **TODO:** consider adding scripts/calc.py for the endo-postop-nadir-gh-ogtt-if-ghgt1 calculator
Is this your skill, or is something wrong with this listing? Request removal or report an issue. Author removals are honored within 72 hours.
No comments yet. Be the first to comment!